Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Total Voting Rights

27 Dec 2006 07:01

ReNeuron Group plc27 December 2006 27 December 2006 (ReNeuron Group plc "The Company") Total Voting Rights For the purposes of the transitional provisions of the Financial ServicesAuthority's Disclosure and Transparency Rules, the Company's total issued sharecapital at the date of this notice is £1,185,241. The Company's issued share capital consists of 118,524,100 ordinary shares of 1peach, with one voting right per share. There are no shares held in treasury. The total number of voting rights in the Company is therefore 118,524,100. The above figure of 118,524,100 may be used by shareholders as the denominatorfor the calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, the Company, under theDisclosure and Transparency Rules. For further information contact:ReNeuron Group plcMichael Hunt, CEO Tel: 44 (0)1483 302 560 Financial DynamicsDavid Yates Tel: 44 (0)20 7831 3113Nicola Daley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Apr 20137:00 amRNSPresentation on Mechanisms of Action
17th Apr 20134:40 pmRNSSecond Price Monitoring Extn
17th Apr 20134:35 pmRNSPrice Monitoring Extension
4th Apr 20134:40 pmRNSSecond Price Monitoring Extn
4th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 20137:02 amRNSCollaboration with Cell Therapy Catapult
27th Mar 20137:00 amRNSDosing Completed in Stroke Trial
26th Mar 20137:00 amRNSApprovals for Stem Cell Trial in CLI
19th Mar 20134:40 pmRNSSecond Price Monitoring Extn
19th Mar 20134:35 pmRNSPrice Monitoring Extension
11th Mar 20137:00 amRNSWins Two Biomedical Catalyst Grants
6th Mar 20134:35 pmRNSPrice Monitoring Extension
25th Feb 20137:00 amRNSAIM Rule 17 Notification
29th Jan 20137:00 amRNSStroke Trial Update: Final Cohort Begins Dosing
11th Jan 20134:40 pmRNSSecond Price Monitoring Extn
11th Jan 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20127:01 amRNSReNeuron to Present at UK Stroke Forum
4th Dec 20127:00 amRNSInterim Results
22nd Nov 20127:00 amRNSNon-Clinical Data
21st Nov 20127:00 amRNSNotification of Interim Results
17th Oct 20127:00 amRNSFurther Progress with Stroke Trial
21st Sep 201212:39 pmRNSTR-1: Notification of Major Interest in Shares
14th Sep 201210:00 amRNSDirectors' Interest in Shares and Share Options
11th Sep 201210:38 amRNSResults of 2012 Annual General Meeting
11th Sep 20127:00 amRNSAGM Trading Update
14th Aug 20127:00 amRNSStroke Trial Update
7th Aug 20129:42 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jul 20127:00 amRNSPosting of Annual Report & Notice of AGM
5th Jul 20124:40 pmRNSSecond Price Monitoring Extn
5th Jul 20124:35 pmRNSPrice Monitoring Extension
28th Jun 20127:01 amRNSSSAG and Non-Executive Board Changes
28th Jun 20127:00 amRNSPreliminary Results
19th Jun 20127:00 amRNSNotification of Preliminary Results
15th Jun 20127:00 amRNSPresents Further Data
14th Jun 20127:00 amRNSPISCES Trial Interim Data
8th Jun 201210:13 amRNSNotice of Major Interest in Shares
21st May 20127:00 amRNSPresentation at World Stem Cells Congress
16th May 20127:00 amRNSCell Manufacturing Contract
11th May 201211:09 amRNSNotifications of Major Interests in Shares
8th May 201210:52 amRNSTR-1: Notification of Major Interest in Shares
3rd May 201212:21 pmRNSAdmission of Open Offer Shares
27th Apr 20123:37 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20123:26 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20127:00 amRNSResult of Placing and Open Offer
20th Apr 20122:54 pmRNSResult of General Meeting
20th Apr 20127:00 amRNSInvestor Conference
19th Apr 201210:16 amRNSNotification of Major Interest in Shares
3rd Apr 20127:00 amRNSPlacing and Open Offer
30th Mar 20127:00 amRNSIssue of Ordinary Shares
27th Mar 20127:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.